Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis (rrms) patients in the combirx trial

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2020
This article has no abstract
Epistemonikos ID: 270ae75c2c081237b7b53b3b6379ae037a376462
First added on: Apr 30, 2026